NCT04968119

Telehealth Exercise Platform to Reduce Frailty After Bone Marrow Transplant

A Novel Telehealth Exercise Platform to Reduce Frailty in Hematopoietic Cell Transplantation Survivors: A Pilot Feasibility Study

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 21 (actual)
• Sponsor: City of Hope Medical Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This clinical trial studies the feasibility of implementing a telehealth exercise platform to reduce frailty in patients after bone marrow transplant. The exercise program uses a telehealth platform (e.g. smart phones, tablets or computers) to view pre-recorded exercise videos on coordination, posture, stretching, balance and resistance/aerobic training. Physical activity may help to improve physical function, including frailty, after bone marrow transplant. Information from this trial may help researchers design future telehealth exercise routines for treating people with cancer.

Detailed description

PRIMARY OBJECTIVE: I. Determine the feasibility of the telehealth exercise program, as evaluated by participation and completion rates. SECONDARY OBJECTIVE: I. Explore the effects of the telehealth exercise program on physical functioning. OUTLINE: Patients are randomized to 1 of 2 arms. ARM A: Patients participate in telehealth exercise sessions at home over 30 minutes with a trainer 3 days a week for 8 weeks (24 total sessions). ARM B: Patients maintain their normal activities of daily living for 8 weeks before participating in the telehealth exercise program as described in Arm I.

Conditions

• Hematopoietic and Lymphoid Cell Neoplasm

Interventions

Type	Name	Description
OTHER	Exercise Intervention	Participate in telehealth exercise sessions
OTHER	Quality-of-Life Assessment	Ancillary studies
OTHER	Questionnaire Administration	Ancillary studies

Timeline

• Start date: 2021-07-12
• Primary completion: 2024-10-08
• Completion: 2024-10-08
• First posted: 2021-07-20
• Last updated: 2025-02-06

Locations

1 site across 1 country: United States